|
|
News Breaks | | | | October 25, 2011 | | 08:27 EDT |  | PIP, SIGA | PharmAthene, SIGA Technologies should merge, says Roth Capital
Roth Capital believes that the best course of action for PharmAthene(PIP) and SIGA (SIGA) would be to merge, although the firm adds that this isn't necessarily the most likely scenario. The firm thinks that both companies would benefit from a merger and it maintains a $6.25 target and Buy rating on PharmAthene. | |
|
News For PIP;SIGA From The Last 14 Days Check below for free stories on PIP;SIGA the last two weeks. |
|
|
| May 8, 2013 | | 16:03 EDT |  | PIP | PharmAthene reports Q1 EPS (4c), one estimate (5c)
 Subscribe for More Information | |
|
|
|
|
|
|
